Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients

Human Pathology

Volumn 27, Issue 2, 1996, Pages 157-164

  Wu, Tsung Teh ^b   Swerdlow, Steven H ^b   Locker, Joseph ^b   Bahler, David ^b   Randhawa, Parmjeet ^b   Yunis, Eduardo J ^b   Dickman, Paul S ^b   Nalesnik, Michael A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

Epstein Barr virus; lymphoproliferative disorders; organ transplantation

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; LYMPHADENITIS; LYMPHOPROLIFERATIVE DISEASE; MALE; MONONUCLEOSIS; MUSCLE TUMOR; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; T LYMPHOCYTE RECEPTOR GENE; TUMOR RECURRENCE;

EID: 0030069114     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90369-X     Document Type: Article

References (28)

1. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al: Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262-4279, 1981
2. Starzl TE, Nalesnik MA, Porter KA, et al: Reversibility of lymphomas and lymphoproliferative lesions developing under Cyclosporine-steroid therapy. Lancet 1:584-587, 1984
3. Nalesnik MA, Jaffe R, Starzl TE, et al: The pathology of posttransplant lymphoproliferative disorders occurring in the setting of Cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173-192, 1988
4. Knowles DM, Cesarman E, Chadburn A, et al: Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferastive disorders. Blood 85:552-565, 1995
5. Swerdlow SH: Post-transplant lymphoproliferative disorders: A morphologic, phenotypic and genotypic spectrum of disease. Histopathology 20:373-385, 1992
6. Hanto DW, Frizzera G, Purtilo DT, et al: Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 41:4253-4261, 1981
7. Nalesnik MA, Locker J, Jaffe R, et al: Clonal characteristics of posttransplant lymphoproliferative disorders. Transplant Proc 20:280-283, 1988
8. Cleary ML, Nalesnik MA, Shearer WT, et al: Clonal analysis of transplant associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72:349-352, 1988
9. Locker J, Nalesnik M: Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135:977-987, 1989
10. Randhawa PS, Jaffe R, Demetris AJ, et al: The systemic distribution of Epstein-Barr virus genomes in fatal posttransplant lymphoproliferative disorders: An in-situ hybridization study. Am J Pathol 138:1027-1033, 1991
11. Armitage JM, Kormos RL, Stuart S, et al: Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of Cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877-886, 1991
12. Benkerrou M, Durandy A, Fischer A: Therapy for transplantrelated lymphoproliferative diseases. Hem Oncol Clin North Am 7:467-75, 1993
13. Hanto DW, Frizzera G, Gajl-Peczalska K, et al: Epstein-barr virus-induced B-cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal and monoclonal B-cell proliferation. N Engl J Med 306:913-918, 1982
14. National Cancer Institute-Sponsored Study of Classifications of Non-Hogkin's Lymphoma: Summary and description of a Working Formulation for clinical usage: The non-Hodgkin's lymphoma pathologic classification project. Cancer 49:2112-2135, 1982
15. Weiss LM, Chen YY, Liu XF, et al: Epstein-Barr virus and Hodgkin's disease: A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139:1259-1265, 1991
16. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889, 1986
17. Bahler DW, Berry G, Warnke RA, et al: Diversity of T cell antigen receptor variable genes used by mycosis fungoides cells. Am J Pathol 140:1-8, 1992
18. Nalesnik MA, Randhawa P, Demetris AJ, et al: Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder (PTLD) in a liver transplant recipient. Cancer 72:2568-2573, 1993
19. Lee ES, Locker J, Nalesnik M, et al: The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 332:19-25, 1995
20. Purtilo DT: Opportunistic cancers in patients with immunodeficiency syndromes. Arch Pathol Lab Med 111:1123-1129, 1987
21. Purtilo DT, Strobach RS, Okano M, et al: Epstein-Barr virusassociated lymphoproliferative disorders. Lab Invest 67:5-23, 1992
22. Frizzera G: Atypical lymphoproliferative disorders, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, pp 459-495
23. Nalesnik MA, Starzl TE: Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci 4:60-75, 1994
24. McClain KL, Leach CT, Jenson HB, et al: Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 332:12-18, 1995
25. Shapiro RS, Chauvenet A, McGuire W, et al: Letter. Treatment of B-cell lymphoproliferative disorders with interferon-alpha and intravenous gamma globulin. N Engl J Med 318:1334, 1988
26. Papadopoulos EB, Ladanyi M, Emanuel D, et al: Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330:1185-1191, 1994
27. Epstein MA, Morgan AJ, Finerty S, et al: Protection of cottontop tamarins against Epstein-barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 318:287-289, 1985
28. Roth G, Curiel T, Lacy J: Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells. Blood 84:582-587, 1994